Physician
Retina Consultants, PLLC
Retina Consultants, PLLC was paid $13.63M by Medicaid between Jan 2018 and Dec 2024, across 19 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 68% of everything it billed.
33Billing provider infoRETINA CONSULTANTS, PLLC
CHARLESTON, WV 25301
CHARLESTON, WV 25301
33aNPI1902800758assigned 06/09/2005
33bProvider typeOphthalmology Physician
28Total paid$13.63M
24GClaims123,085
24DCodes billed19
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ophthalmology Physician providers in West Virginia
Rank by total paid#1 of 27
Median peer was paid$73K
This provider vs. median187×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,844 | $1.65M | |
| 2019 | 15,955 | $1.44M | |
| 2020 | 16,532 | $1.87M | |
| 2021 | 17,962 | $1.81M | |
| 2022 | 19,345 | $2.62M | |
| 2023 | 20,738 | $2.56M | |
| 2024incomplete | 14,709 | $1.69M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 68% | 14,375 | 8,888 | $9.33M |
| 67028 | Intravitreal injection of a pharmacologic agent | 10% | 29,740 | 19,081 | $1.41M |
| 92134 | 7.6% | 43,211 | 28,770 | $1.04M | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 2.5% | 9,361 | 5,811 | $335K |
| J9035 | Injection, bevacizumab, 10 mg | 2.0% | 4,036 | 2,924 | $267K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.2% | 5,431 | 3,910 | $167K |
| 92250 | 1.2% | 3,690 | 2,752 | $167K | |
| 92235 | 1.2% | 2,583 | 1,983 | $162K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1.2% | 3,254 | 2,571 | $161K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.1% | 3,788 | 2,673 | $155K |
| 67228 | <1% | 767 | 546 | $135K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 1,047 | 822 | $82K |
7 more codes
| J2777 | Injection, faricimab-svoa, 0.1 mg | <1% | 102 | $72K |
| 67210 | <1% | 173 | $53K | |
| J0177 | Injection, aflibercept hd, 1 mg | <1% | 15 | $51K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 362 | $32K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 247 | $12K |
| J3590 | Unclassified biologics | <1% | 181 | $2K |
| 99024 | 0% | 722 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDUNDERVILL, ROBERT (MANAGING PARTNER)